InvestorsObserver
×
News Home

Should You Add Pulse Biosciences Inc (PLSE) Stock to Your Portfolio Wednesday?

Wednesday, November 29, 2023 12:16 PM | InvestorsObserver Analysts

Mentioned in this article

Should You Add Pulse Biosciences Inc (PLSE) Stock to Your Portfolio Wednesday?

Pulse Biosciences Inc (PLSE) is around the top of the Healthcare sector according to InvestorsObserver. PLSE received an overall rating of 99, which means that it scores higher than 99% of stocks. Additionally, Pulse Biosciences Inc scored a 84 in the Healthcare sector, ranking it higher than 84% of stocks in that sector.

Overall Score - 99
PLSE has an Overall Score of 99. Find out what this means to you and get the rest of the rankings on PLSE!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. *Investors Observer* allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 99 would rank higher than 99 percent of all stocks. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in the healthcare sector with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Pulse Biosciences Inc Stock Today?

Pulse Biosciences Inc (PLSE) stock is trading at $9.35 as of 11:56 AM on Wednesday, Nov 29, a rise of $0.61, or 6.98% from the previous closing price of $8.74. The stock has traded between $8.57 and $10.21 so far today. Volume today is above average. So far 320,779 shares have traded compared to average volume of 179,075 shares. Click Here to get the full Stock Report for Pulse Biosciences Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App